Catamaran Bio

Total Funding
$42.0M
Last Round
$42.0M Series ANov 2020
Rounds
1

About

NK cell therapy platform for solid tumors

Summary

It has raised $42.0M in total across 1 round, most recently a $42.0M Series A round in Nov 2020. Investors include SV Health Investors, Sofinnova Partners and Lightstone Ventures.

Sign up to view funding chart

Create a free account to see funding visualizations and detailed round data.

Funding History

Investors